New search | Conferencedetail
Print view
 
 

Tumor Myeloid Microenvironment Directed Therapeutics Summit 2021

Evvnt Promotion / evvnt
-
16.03.2021 - 18.03.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Conference themes
With the explosive excitement and clinical proof of concept utilizing CD47 approaches, 2020 is the year for macrophage development, as we witness greater interest and investment in new work on novel macrophage targets outside of CD47.

Tumor Myeloid Microenvironment Directed Therapeutics Summit is focused on optimizing the potential of immunotherapy, through direct modulation of tumor-resident myeloid populations to retune the microenvironment for improved response rates to therapy.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/701752-3?pid=4832

Speakers: Peter Ellmark, Alligator Bioscience AB, Victoria Smith, Amphivena Therapeutics Inc., Kaiming Ye, Binghamton University, Michael Klichinsky, Carisma Therapeutics and more
 

Enquiries and Registration:

https://go.evvnt.com/701752-0?pid=4832
Ms. Aarti Diwan
 
Categories
General Medicine, Health Services
Languages
English
Congress fees
USD 1499.00 - USD 2997.00
Participants expected
1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Anästhesie in Entwicklungsländern e. V.Center of ExcellenceÄrztekammer für WienÄrzte der WeltEuropean Public Health Association (EUPHA)Helix - Forschung & Beratung WienEuropean Health Forum GasteinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation